Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva®) in Patients with Multiple Sclerosis: An Observational Retrospective Study

Roya Abolfazli*, Mohammad Ali Sahraian, Atefeh Tayebi, Hamidreza Kafi, Sara Samadzadeh*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

22 Downloads (Pure)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva®) in Patients with Multiple Sclerosis: An Observational Retrospective Study'. Sammen danner de et unikt fingeraftryk.

Pharmacology, Toxicology and Pharmaceutical Science